Caricamento...
PPARα Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil
Gemfibrozil, a peroxisome proliferator-activated receptor α (PPARα) agonist, is widely used for hypertriglyceridemia and mixed hyperlipidemia. Drug-drug interaction of gemfibrozil and other PPARα agonists has been reported. But the role of PPARα in Cytochrome P450 (CYP) induction by fibrates is not...
Salvato in:
| Pubblicato in: | Basic Clin Pharmacol Toxicol |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5554081/ https://ncbi.nlm.nih.gov/pubmed/28374976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcpt.12794 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|